Previous 10 | Next 10 |
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). Markets are getting some more relief as the PBOC set its official midpoint reference for the yuan at...
Merger activity decreased last week with three new deals announced and ten pending deals closing. Deal Statistics: New Deals: The acquisition of Genomic Health ([[GHDX]]) by Exact Sciences Corporation ([[EXAS]]) for $2.8 billion in a cash-plus-stock deal. Under the terms of the ...
AbbVie (ABBV) is undervalued, and the company's plan to acquire Allergan ( AGN ) will provide both needed diversification and a focused use for the current torrent of free cash flow that AbbVie earns. More than half of AbbVie's sales come from Humira, a blockbuster immunosuppressive medication...
The AES Corporation. (AGN) Q2 2019 Results Earnings Conference Call August 06, 2019, 09:00 AM ET Company Participants Ahmed Pasha - Vice President of Investor Relations Andrés Gluski - President and CEO Gustavo Pimenta - EVP and CFO Conference Call Participants Angie S...
Allergan ( AGN ) Q2 results : Revenues: $4,090.1M (-0.8%); US Specialized Therapeutics: $1,785.1M (-2.3%); US General Medicine: $1,455.7M (+10.3%); International: $847.7M (-10.7%). More news on: Allergan plc, Healthcare stocks news, Earnings news and commentary, Read more ...
DUBLIN , Aug. 6, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today reported its second quarter 2019 financial results including GAAP net revenues of $4.09 billion , a 0.8 percent decrease from the prior year quarter. Excluding foreign exchange impact, second quarter 2019 non-GAAP ...
Disneyland will never be completed. It will continue to grow as long as there is imagination left in the world." - Walt Disney For the most part, the second quarter saw a continuation of the first quarter's positive performance across many asset classes. This furthered a reversal o...
Musings July 2019 was another month that was hard to predict as the market held its breath for the Fed rate decision. At the risk of sounding like a broken record, I again underperformed the S&P 500 (1.4% vs -0.8%), but this was my first month of splitting directions with the market in...
Quick Take InMode ( INMD ) has filed to raise gross proceeds of $75 million from a U.S. IPO, according to an F-1/A registration statement . The firm provides minimally-invasive surgical aesthetic and medical treatment solutions for physicians. INMD is growing smartly, is profitable and ...
DUBLIN , Aug. 2, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced it will release second quarter 2019 financial results on Tuesday, August 6, 2019 , prior to the open of U.S. financial markets. For additional materials related to Allergan's second quarter resul...
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 17:08:02 ET About to begin a phase 2b/3 multinational study of Ifenprodil Algernon Pharmaceuticals is a drug repurposing company. They're a phase 2 clinical stage company advancing a drug called Ifenprodil for idiopathic pulmonary fibrosis, but also as a potential thera...
2024-03-27 17:08:02 ET A stroke can be a devastating and debilitating event for an individual and their family, and a major burden on the health care system. Over 15 million people suffer strokes every year, and 85% of those have some form of disability as a result. Stroke-related cos...
2024-03-27 17:08:02 ET Stocks to Invest in: Healthcare Focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease Algernon is a drug re-purposing company that investigates safe, already approved drugs, inclu...